https://webnewsinsider.com/how-amivantamabs-dual-egfr-met-blockade-overcomes-resistance-in-head-and-neck-cancer/ WebNewsInsider en 2026-11-06T08:22:18+08:00 How Amivantamab’s Dual EGFR-MET Blockade Overcomes Resistance in Head and Neck Cancer https://webnewsinsider.com/claudes-new-personal-finance-tool-lets-users-spot-spending-leaks-via-chat/ WebNewsInsider en 2026-11-06T01:12:11+08:00 Claude’s New Personal Finance Tool Lets Users Spot Spending Leaks via Chat https://webnewsinsider.com/why-aca-premiums-are-rising-again-in-2027/ WebNewsInsider en 2026-11-05T18:11:48+08:00 Why ACA Premiums Are Rising Again in 2027 https://webnewsinsider.com/bank-of-england-raises-interest-rate/ WebNewsInsider en 2026-11-05T13:25:26+08:00 Bank of England Raises Interest Rate https://webnewsinsider.com/new-start-site-at-romes-regina-elena-removes-trial-barriers-for-italian-patients/ WebNewsInsider en 2026-11-05T07:13:33+08:00 START Opens First Italian Early-Phase Cancer Trial Site in Rome https://webnewsinsider.com/personalized-tms-shows-promise-for-severe-ocd-in-singapore-study/ WebNewsInsider en 2026-11-05T07:11:49+08:00 Personalized TMS Shows Promise for Severe OCD in Singapore Study https://webnewsinsider.com/how-a-310000-investment-gain-can-boost-medicare-premiums-for-retirees/ WebNewsInsider en 2026-11-05T01:23:51+08:00 How a $310,000 Investment Gain Can Boost Medicare Premiums for Retirees https://webnewsinsider.com/inovios-first-fda-approval-tests-whether-dna-medicines-can-pay-off-for-retail-investors/ WebNewsInsider en 2026-11-05T00:11:23+08:00 Inovio’s First FDA Approval Tests Whether DNA Medicines Can Pay Off for Retail Investors